CHARLES RIVER LABORATORIES CELL SOLUTIONS, INC. - CD34+ STEM/PROGENITOR CELLS
Key Details
Description
CD34+ STEM/PROGENITOR CELLS
Context & Analysis
On Feb 10, 2026, Department of Health and Human Services obligated $24,969 to CHARLES RIVER LABORATORIES CELL SOLUTIONS, INC. for cd34+ stem/progenitor cells. The award is classified under NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in SILVER SPRING, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325414 — related awards are listed below.
Contractor Information
Similar Awards
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
SANOFI VACCINES US INC.
$612.2M
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
ADVANCED TECHNOLOGY INTERNATIONAL
$304.0M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
Stay Updated
Get notified about new opportunities matching your interests.